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Abstract 
The purpose of this metasynthesis was to describe the views of adults with neurodegenerative 
diseases on end-of-life care. Thirteen qualitative studies were included and a metasynthesis 
design was employed to integrate the findings. Four analytical themes were identified; 1) 
Importance of autonomy and control; 2) It’s the role of healthcare professionals to get the 
balance of information right; 3) Decision-making occurs in context; 4) Care can’t meet all your 
needs. Participants’ views were framed by the context of their lives and these shaped their 
engagement with end-of-life care. Palliative care would be beneficial in meeting the needs of 
adults with neurodegenerative diseases 
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The views of adults with neurodegenerative diseases on end-of-life care: a 
metasynthesis 
End-of-life care is a prevalent health care issue worldwide. Palliative care offers a 
theoretical model of end-of-life care for people with life-limiting conditions and is promoted by 
the World Health Organization (WHO) as the preferred approach (WHO, 2002). Conceptually, 
the aim of palliative care is to improve the quality of life of patients with life-threatening illneses 
and their families by providing compassionate care that emphasises the importance of attending 
to individuals’ psychological and spiritual needs as well as the physical aspects of dying 
(Morrison & Meier, 2004). Accordingly, central importance is placed on the wishes of the dying 
individual. Effective palliative care has three main aims: management of physical symptoms and 
side effects; continuing communication of treatment goals between doctor, patient and family; 
and psychological, spiritual and social support for patient and family. 
Despite the rapid growth of palliative care across the world since its conception as part of 
the modern hospice movement, death remains largely medicalised (Clark, 2002). As a result of 
medical advancement, life expectancy has broadly increased over time; however, it is not clear 
whether living significantly longer is associated with living better or diminished suffering. For 
instance, Zimmermann and Rodin (2004) argue that the “technological imperative” of medicine 
has resulted in depersonalised care. They propose that the only constraint on intervention in 
modern medicine is the sophistication of the technology, which results in a situation where life 
prolonging treatments are done because they are possible, rather than in the best interest of the 
individual. Congruently, Yuill (2015) argues that medical science has made it possible to sustain 
life beyond the point of desirability. Consequently, a strong argument has been made for 
increased quality rather than quantity of life being the overt goal of end-of-life care.  
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Nevertheless, end-of-life care is a contentious issue (Zimmermann & Rodin, 2004). 
Although there is agreement between healthcare professionals and patients that improvement in 
end-of-life care is possible and desirable, it remains unclear what quality care means 
conceptually to patients and their families, what role the state should play in end-of-life care and 
how best to evaluate ‘good’ end-of-life care (e.g. Earle, 2003; Teno, 2004).  
Research has sought to improve understanding of quality end-of-life care. For example, a 
systematic review by Hinkle, Bosslet & Torke (2015) found that high quality, empathic 
communication, collaborative decision-making support and specific care measures that prepared 
patients for the end of life were associated with increased family satisfaction with end-of-life 
care. Similarly, a meta-analysis by Gomes et al. (2013) revealed statistically significant 
beneficial effects of home palliative care services compared to usual care on reducing the impact 
of symptoms. 
Furthermore, Heyland et al. (2006) conducted a survey of people with chronic end-stage 
disease and their families and found that the most important aspects of good end-of-life care 
were trust in health care professionals, avoiding life-prolonging treatments where meaningful 
recovery was unlikely, open and honest communication, continuity of care and ‘completing’ life. 
This survey was based on qualitative accounts related to good end-of-life care, suggesting that 
qualitative research is consistent with the findings of quantitative research in this area.  
Neurodegenerative diseases 
A systematic review by Zimmermann, Riechelmann, Krzyzanowska, Rodin and Tannock 
(2008) demonstrated that palliative care approaches improve family satisfaction with care for 
people with chronic conditions. However, evidence further suggests that access to palliative care 
is predominantly restricted to people with cancer (Solano, Gomes, & Higginson, 2006). 
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Neurodegenerative diseases, which are largely adult-onset, including Alzheimer’s disease (AD), 
Parkinson’s disease (PD), Huntington’s disease (HD) and motor neuron disease
1
 (MND), are 
characterised by progressive loss of structure or function of neurons, including neuronal cell 
death. Each of these diseases is distinct but they share a number of characteristics, such as loss of 
functioning in a range of domains, and are thought to have cellular and molecular mechanisms 
leading to cell degeneration in common, such as protein aggregation and inclusion body 
formation (Ross & Poirier, 2004). It is estimated that, since 2002, chronic conditions (of which 
degenerative diseases are included) are the largest cause of death globally (WHO, 2008). Despite 
their capacity to cause significant morbidity and shorten life, neurodegenerative diseases are not 
typically associated with palliative care (Luddington, Cox, Higginson, & Livesley, 2001). 
Research suggests that the quality of end-of-life care for people with neurodegenerative diseases 
is often poor (e.g. Borasio & Voltz, 1997; McGarva, 2001). This is in spite of the fact that people 
with neurodegenerative diseases are often aware in advance that their cognitive abilities and 
capacity for communication will decline and for some (e.g. MND) the time from diagnosis to 
death is relatively short. 
It is possible that there are significant challenges with the implementation of palliative 
care in this population. For example, historically palliative care has followed a cancer model. 
Disease trajectories for neurodegenerative diseases are more variable, ranging from years to 
decades, and so prognosis is uncertain (Goldstein & Morrison, 2013). A further barrier may be 
the beliefs and attitudes of healthcare professionals; for example, beliefs that palliative care 
should only be offered at the end stage of an illness, or negative attitudes due to the irrevocability 
of disease progression (Kristjanson, Toye, & Dawson, 2003), which may be conveyed to patients 
                                                 
1
 The UK term Motor neurone disease is used throughout this synthesis, which is also known as 
amyotrophic lateral sclerosis (ALS) 
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and families. Additionally, there may be issues with active decision-making as a result of 
capacity and ability to communicate diminishing over time (S. A. Simpson, 2007). 
However, due to the broad scope of the definition of palliative care, it can in principle be 
integrated with curative treatment and need not preclude life-prolonging treatments. This, 
therefore, suggests that it is desirable for palliative care to be implemented as part of the routine 
care of people with neurodegenerative diseases. A systematic review (Siouta et al., 2016) 
indicated increasing appreciation for the value of integrated palliative care in patients with life-
limiting non-cancer conditions and suggested the need for the development of standardised 
strategies so that barriers to implementing an integrated approach are lessened. This is congruent 
with the position of the WHO, which has indicated that the need for palliative care for people 
with life-threatening conditions begins at the point of diagnosis (WHO, 2002). 
Comparable with end-of-life care, it is argued that treatments for neurodegenerative 
diseases are also highly medicalised. To illustrate, in relation to AD, Bartus (2000) argues that 
scientific interest in palliative treatments has declined and been superseded by efforts to 
understand the process of neurodegeneration through molecular approaches. In support of this, it 
is frequently presumed that biological factors are the primary causes of psychological problems 
in neurodegenerative diseases (e.g. Eccles, Murray, & Simpson, 2011; Matchwick, Domone, 
Leroi, & Simpson, 2014) and, accordingly, medical interventions are most frequently used to 
address them (e.g. Bonelli, Wenning, & Kapfhammer, 2004). However, their effectiveness has 
generally been found to be limited. For example, a systematic review by Drijgers, Aalten, 
Winogrodzka, Verhey and Leentjens (2009) found that there was insufficient evidence to support 
pharmacological treatment for apathy in neurodegenerative diseases. 
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Notwithstanding the promise of biomedical approaches, it is widely acknowledged that 
the psychological and social aspects of living with a neurodegenerative disease are as vital and 
worthy of attention as physical care. For example, in HD, Arran, Craufurd and Simpson (2014) 
found that a number of psychological factors were associated with higher levels of depression 
and these were more predictive of distress than more clinical variables (such as severity). 
Conversely, in PD, the results of an international survey reveal that the severity of disease and 
effectiveness of pharmacological interventions combined only accounted for 17% of the variance 
in health-related quality of life (Global Parkinson’s Disease Survey Steering Committee, 2002). 
Similarly, a study by Ho, Gilbert, Mason, Goodman and Barker (2009) suggested that 
psychological variables were more useful than any other in predicting health-related quality of 
life in HD. This indicates that a psychological framework may be useful. 
Despite the importance of qualitative research in understanding people’s views, existing 
research on psychosocial aspects of neurodegenerative diseases is predominantly quantitative. 
Multidimensional constructs such as quality of life (Finlay & Dunlop, 1994) or coping are often 
quantified in attempt to measure subjective experiences (e.g. Chiò et al., 2004; Pace et al., 2009). 
This data may not therefore wholly reflect the experience of the individual. Despite this, 
qualitative approaches are well suited to exploring views and experiences (Smith, 2007) and 
there is a robust precedent for metasyntheses focusing on the needs and views of people in 
healthcare settings (e.g. Hodge & Horvath, 2011; Waibel, Henao, Aller, Vargas, & Vázquez, 
2012).  
It is important to understand the views of people with neurodegenerative diseases because 
research has shown that affected individuals, carers and families are generally aware of their 
needs and would wish to plan ahead (Kristjanson et al., 2003). It was decided that it was timely 
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and necessary to conduct a qualitative metasynthesis to explore the views of people with 
neurodegenerative diseases on end-of-life care because there is extant research in this area but to 
date there has been no qualitative review addressing this issue. Although individual qualitative 
studies may offer insight into the views of people with neurodegenerative diseases they are 
limited in scope and do not necessarily provide a comprehensive understanding. Synthesising 
extant research can enhance the generalisability of qualitative evidence (Sandelowski, Docherty, 
& Emden, 1997). Therefore, the purpose of this study is to review the empirical qualitative 
literature relating to the views of people with neurodegenerative diseases on end-of-life care in a 
systematic way. This will enable an overview of the existing research, potentially identifying 
areas for future study, illuminating service provision needs and offering ideas for good practice 
for specialist palliative care services. 
Method 
Research question 
The review aimed to understand what the views of people with neurodegenerative 
diseases on end-of-life care are in end-of-life care. This question is expansive enough to 
encapsulate the phenomenon of interest and the synthesis of studies of different 
neurodegenerative diseases should yield fresh insights and conceptual development beyond that 
of reading individual studies. 
Data collection 
A systematic search of four electronic databases (Academic Search Complete, PubMed, 
Cumulative Index to Nursing and Allied Health Literature (CINAHL) and PsycINFO) was 
conducted in January 2016. Research was drawn from databases across psychological, social, 
medical and nursing disciplines to ensure a wide reach. 
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In order to identify search terms, the research question was separated into its essential 
parts: neurodegenerative diseases and end-of-life care. Search terms were generated by hand 
based on these two areas (see Table 1) and refined using the index terms for each database (for 
example, subject headings, APA descriptors, database thesauruses and the MeSH ‘explode’ 
function was used in databases where this was an option. The search terms were combined using 
the Boolean terms ‘and’ and ‘or’.  
Insert Table 1 here 
 
Inclusion and exclusion criteria 
The selected studies were screened using the following inclusion criteria: papers must (a) 
explore the views or experiences of participants who have an adult-onset neurodegenerative 
disease in relation to end-of-life care, (b) report findings of qualitative research using accepted 
qualitative methods of data collection and analysis, (c) be available in English and (d) be 
published in a peer-reviewed journal. No additional exclusion criteria were applied. 
Neurodegenerative disorders are one of the most problematic classifications of disease 
(Du & Pertsemlidis, 2011). The definition of neurodegenerative diseases posited by Przedborski, 
Vila and Jackson-Lewis (2003, p.1) was used: “neurological disorders with heterogeneous 
clinical and pathological expressions affecting specific subsets of neurons in specific functional 
anatomic systems; they arise for unknown reasons and progress in a relentless manner”. 
Therefore, neoplasm, oedema, haemorrhage, and trauma of the nervous system are not 
considered to be neurodegenerative disorders and were not included. Nor were pathologies in 
which neurons die due to a known cause, such as infection or poisoning. Multiple sclerosis was 
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included, however, as some evidence suggests that it is principally a neurodegenerative disease 
rather than an autoimmune disease (e.g. Chaudhuri, 2013).  
An inclusive approach was taken to end-of-life care, to include anyone with a terminal or 
life-limiting condition that has become advanced, progressive and incurable, not only people in 
the final stages of life (Gysels et al., 2013). 
The lead researcher initially assessed the titles and abstracts, and full text studies were 
obtained and screened if they appeared to meet the inclusion criteria. Studies that focused on the 
perspective of caregivers, family members, or healthcare professionals were excluded unless 
reported separately. Sandelowski & Barroso (2003) suggest a classification system for appraising 
the quality of analysis of research. Consistent with the recommendations of this system, ‘no-
finding’ studies (e.g. articles consisting of uninterpreted narratives or diaries) and topical survey 
studies were excluded from the metasynthesis. To illustrate, a single case report by Mitsumoto & 
Rabkin (2007) was excluded, despite its use of rich quotes, because no qualitative analysis was 
evident and it was deemed a ‘no-finding’ study. Figure 1 summarises the application of the 
inclusion and exclusion criteria to the papers found. 
Insert Figure 1 here 
 
Critical appraisal 
The quality of each study was appraised using the Critical Appraisal Skills Program 
(CASP) checklist for qualitative research (Public Health Resource Unit, 2006) to identify 
potential limitations. A three-point numerical scoring system was used, developed by Feder, 
Hutson, Ramsay and Taket (2006), whereby papers were given a score of 0-2 on each of the 
CASP’s criteria out of a possible 10. The purpose of this appraisal was not to exclude studies, as 
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there is little rationale for doing so based on methodological quality (Bondas & Hall, 2007), but 
to give weighting to their contribution in the synthesis (Topcu, Buchanan, Aubeeluck, & Garip, 
2016). All papers scored sufficiently highly and none of the papers were given less emphasis (see 
Table 2).  
Insert Table 2 here 
 
Characteristics of the selected studies 
The thirteen selected studies had sample sizes ranging from 2-34 people. Diagnoses 
included HD, MND, MS, dementia and PD and participants varied widely in stage of disease. 
Seven of the selected studies noted that they used semi-structured interviews, one study used 
narrative interviews (employing a variety of modes of communication including email, diary and 
telephone), three studies did not detail the structure of their interviews, describing them as ‘in-
depth interviews’, one study reportedly used ‘episodic face-face interviews’ and one study used 
autobiographies. Five of the selected studies used grounded theory, four studies used thematic 
analysis, two studies used narrative analysis, one study used ‘manifest’ qualitative content 
analysis, one study used the ‘constant comparison method’ and one study used a 
‘phenomenonological’ approach to analysis. 
The studies took place in a variety of settings, predominantly, individuals’ homes, as well 
as hospitals, outpatient clinics, hospices and nursing homes. One study stated a private and quiet 
place of choice for participants.  
Two studies used the same participants; however, they each provided a novel set of 
findings that were complementary as opposed to identical. Consequently, both studies were 
included in the metasynthesis. See Table 3 for more in-depth characteristics of the studies. 
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Insert Table 3 here 
 
Data extraction, analysis and synthesis 
An inductive thematic synthesis approach was used to synthesise the original content of 
the studies and produce a more advanced understanding through interpretive themes. The three 
conceptual stages of thematic approach to metasynthesis identified by Thomas and Harden 
(2008) were followed: the ‘line-by-line’ coding of text; the development of descriptive themes; 
and the generation of ‘analytical themes’.  
Each paper was read and re-read so that the lead researcher became familiarised with and 
immersed in the data. Reflective notes were kept at this stage to enhance depth of understanding. 
The studies were then coded, much as they would be in primary qualitative research, to capture 
the themes within the original studies relating to the review question on people’s views on end-
of-life care.  
The codes were then analysed, identifying differences and similarities between them, to 
generate an initial set of descriptive themes. These descriptive themes did not attempt to 
reinterpret the primary findings; closeness to the original data sets was felt to be essential in this 
secondary analysis. These themes were considered to extract the meaning of studies in a 
consistent way that was close to the original interpretations of the respective authors.  
Finally, more interpretative analytical themes were refined from the descriptive themes. 
These analytical themes are more tacit, abstract entities and attempt to capture the essence of the 
data (DeSantis & Ugarriza, 2000). This process can be seen as analogous to the development of 
'third order interpretations' in meta-ethnography (Britten et al., 2002). The process and the 
contribution of each paper to each analytical theme is provided in Table 4. 
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Insert Table 4 here 
 
Results 
Four analytical themes were identified in the analysis of the interview data, which are detailed 
below with supporting quotations from the data.  
Importance of autonomy and control 
A strong sense of the importance of autonomy and control ran through participants’ 
accounts. For example, participants wanted to take an active role in decision-making about their 
care. Although there was wide variation in individuals’ wishes (for example, for life-prolonging 
treatments, for hastened death, or for preferred place of death), participants were clear that these 
views should be respected and they should be involved in reaching a final decision. “And I 
would like to know how it will be managed and what my choices are” (Whitehead, O’Brien, 
Jack, & Mitchell, 2012, p.372). A minority of participants across studies appeared to have 
completed advance care directives
2
 to articulate and formalise their intentions regarding their 
care. However, a lack of awareness of advance care directives was also present across studies 
with many participants communicating general wishes about their future care without having this 
documented. “We’re dealing with things as we have to, and it’s probably not a bad way of going 
about it. And just thinking I’ll worry about it when it gets here. I can’t worry about it before” 
(Greenaway et al., 2015, p.1009). 
Desire for autonomy and control occurred in the context of participants’ feeling that they 
had reduced control over many aspects of their lives as a result of their illnesses. Participants 
were acutely aware of the progression of their neurodegenerative disease and spoke about this 
                                                 
2
 An advance care directive, also known as living will, personal directive, advance directive, or advance 
decision, is a legal document specifying what care an individual agrees to in the event they can not make 
decisions for themselves. 
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affecting their ability to make active decisions. For example, some people felt that their choices 
about medical interventions were restricted because of their condition. “It’s not a choice, you 
either use it or can’t breathe of a night, so there is no choice.” (Greenaway et al., 2015, p.1005). 
Conversely, other participants felt reassured by making active decisions about their care. “I felt 
absolutely no control so I said to them [healthcare professionals]…Now I’m able to sit down and 
discuss it [end-of-life care] with them… make decisions when you are in control [of care]” 
(Foley, Timonen, & Hardiman, 2014b, p.321). 
Loss of autonomy was associated with diminished quality of life and meaningfulness.  
I asked about a possible trache and ventilator for the future. He said a definite ‘NO’, he 
wouldn’t advise it and neither would the other consultant there. The main reason was 
expense of care package. But what about what I want!!!! That didn’t seem to matter… 
Maybe he hopes by then I won’t be well enough to discuss it. I feel useless and as if my 
life isn’t even worth talking about (Whitehead et al., 2012 p.372). 
It can be seen from this participant’s account that she did not feel included in decision-making, 
which affected her mood and self-worth.  
Some participants questioned the value of life-prolonging treatments given the life-
limiting nature of their neurodegenerative diseases, perceiving that interventions could 
potentially prolong suffering. This was seen as unacceptable and participants talked about 
disengaging from care, for example, by refusing life-prolonging treatments and supportive care, 
when this was anticipated. For this group, autonomy over when and how to engage with their 
care was more important than extending their life.  
Congruently, difficult decisions about life and death accompanied EOL care. Euthanasia 
and assisted dying were options chosen by some participants in countries where these was legal, 
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and wished for in countries where these were not. Hastened death represented a relief from 
suffering for some participants as well as a way of taking control of their situation when it 
became unbearable by choosing the manner and time of their death.  
I have said for ages, that if I could go to bed tonight, and not wake up, I’d be happy. I’d 
take that… The end will be a big relief. Even though there is no pain, no physical pain, 
there is mental pain, and I’m not saying that I am looking forward to the end but when it 
comes it will be a relief, won’t it? (Whitehead et al., 2012, p.375). 
Conversely, euthanasia and assisted dying were antithetical to some people’s principles and 
therefore rejected. A minority wished to preserve life despite their impending decline, although 
this group did acknowledge feeling disturbed by the idea of severe physical impairment. 
Nevertheless, it can be seen that self-determination was important for participants, regardless of 
their beliefs. 
It’s the role of healthcare professionals to get the balance of information right  
This theme conceptualised the information needs of participants and their, often implicit, 
belief that health care professionals are responsible for meeting these. Many participants spoke 
about a lack of information about their care, which inhibited their ability to make fully informed 
choices. “I didn’t get the brochures or anything from the doctors… there’s really not much there 
to help” (Giles & Miyasaki, 2009, p.121). Similarly, some participants felt that there was a lack 
of awareness of their neurodegenerative disease, even amongst health professionals, which added 
to their feelings of frustration. Some participants talked about managing the lack of information 
from healthcare professionals by actively seeking out information (e.g. from the internet). In 
contrast, some participants felt that they had all the information they needed, which enabled them 
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to make confident decisions. “They covered everything I wanted to know and the questions they 
asked were the right questions” (Poppe, Burleigh, & Banerjee, 2013, p.3).  
Generally, there was ambivalence within and across studies over how much information 
is enough. Many participants wanted information to be able to make decisions about their care 
but reported anxiety about the prospect of a bleak prognosis. Fear of confronting their potential 
deterioration and death meant that some participants rejected advanced care-planning 
discussions, finding them futile or dispiriting. This variability in individuals’ information needs 
illustrates the complex task facing healthcare professionals. 
 Most participants valued their experiences of advanced care planning, finding it a helpful 
experience that gave them important information, the opportunity to have important 
conversations with loved ones, alleviated their worries about their care in the future and 
reassuring them that their wishes would be honoured.  
I suppose really it was the wisest thing to do because there is no use leaving things like 
that too long before things are going to get worse. You don’t know what you are doing… 
I decided to make arrangements and things so if anything happens now they all know, 
what I want and what’s happening so it saves me worrying about it (Poppe et al., 2013, 
p.3).  
However, although participants were aware of concepts such as advance care directives and 
euthanasia, many did not have an understanding of the associated requirements or practicalities 
and, as a result, their wishes for their future care were vague. 
 “We wondered sometimes if it is at all possible. We didn’t know if it might be possible to 
make arrangements now or in fact whether it is possible to make arrangements at all” (Booij, 
Rödig, Engberts, Tibben, & Roos, 2013, p.326).  
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Similarly, participants disclosed their reticence in discussing end-of-life care. Many 
participants expressed their wish to have open conversations about end-of-life care but not 
knowing what to ask for or feeling able to raise this difficult topic. Accordingly, their 
expectations of care were not met.  
Participants wanted a trusting relationship with their healthcare professionals and felt 
more reassured about their care when this was realised. Trust was placed in healthcare 
professionals when support and empathy were offered as well as sensitivity to their needs. “I was 
concerned that it was actually something that would help me but could weaken my ability in the 
daytime. And it really reassured me that actually it would make it better. That was what I wanted 
to hear.” (Greenaway et al., 2015, p.1007). It is possible that trust is a key determinant of 
participants’ satisfaction and presupposes other factors that comprise good care. Noticeably, 
when trust was not present participants across studies appeared to be silent and disengage from 
their care. For instance, a number of participants relied on the expertise of their healthcare 
professionals and suggested that healthcare professionals should take responsibility for and guide 
their decision-making. However, a number of participants experienced the expertise of healthcare 
professionals negatively and reported feeling pressured into decisions by healthcare 
professionals. Worryingly, these participants did not communicate their wishes because of 
perceived bias of healthcare professionals. “I wouldn’t go to a doctor, because I feel that the 
doctor may be biased. […] I want a neutral person and that is either my wife or a notary or a 
solicitor” (Burchardi, Rauprich, Hecht, Beck, & Vollmann, 2005, p.70). This group believed that 
the medical precept to first do no harm would prevent healthcare professionals from honouring 
their wishes if they involved withdrawing life-prolonging treatments. This demonstrates how a 
lack of trust prevented people from fully engaging in their care. 
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Decision-making occurs in context 
Participants across studies communicated the importance of contextual factors in their 
end-of-life care. Family, for example, played a central role in decision-making. Most participants 
saw their neurodegenerative disease in a family context and frequently discussed their 
preferences for end-of-life care with family members and came to decisions endorsed by the 
family.  
A prominent desire for participants was not to be a burden on family members. However, 
it was also important for participants to ‘be there’ for families and support and be supported by 
them. This demonstrates the complexity of decision-making. Family could be supportive but also 
demanding and participants often struggled to balance their personal needs with those of the 
family unit. At times this resulted in complex emotions and participants feeling restricted in their 
decision-making about care. For example, on considering assisted suicide one participant 
commented:  
I had to consider my family and the implications. It’s like a suicide… the pebble in the 
water. It spreads out. It affects so many people, and I suppose a lot of family, like with 
suicide, they get angry that you were selfish (Foley, Timonen, & Hardiman, 2014a, p.72).  
Family influenced not only decision-making but practical care. For example, some participants 
refused carers because family members occupied that role. These participants spoke about the 
importance of reciprocal family support. 
Alternatively, where participants had no family to take into account, this influenced their 
choices. “You see, I don’t feel I have the need to hang on at any cost. If I had a husband, wife, 
children, it might be different. So I’m free to make the choice.” (Foley et al., 2014a, p.72). 
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Another important contextual factor was participants’ perceived status in comparison 
with others. Frequent social comparisons were made in order to form opinions on care. These 
were often first-hand experiences, such as family members’ experiences of the end stages of 
neurodegenerative disease.  “Not the way my mother suffered.” (Booij et al., 2013, p.326). 
Having witnessed a parent or other family member affected by the same neurodegenerative 
condition seemed to shape participants’ wishes for end of life. 
 The variability of disease progression complicated decision-making for participants. 
Many participants were acutely aware of situations, points in their trajectory, that they felt would 
be unbearable and lead them to seek means to hasten their death.  
…As soon as I become dependent on others, then it is time to pull the plug. When I am 
not able to eat independently or be independent, that is unacceptable. If my quality of life 
diminishes to a point that I become dependent, then I quit (Booij et al., 2013, p.326). 
The concept of time therefore influenced participants’ views on EOL care. Some participants 
made the conscious choice to ‘live in the moment’, which meant decisions on interventions 
represented that particular situation in time. However, participants were cognisant that they 
might change their mind in the future and revisit these decisions. “I was going to write a living 
will but I’ve decided with my GP (general practitioner)
 3
 now that there’s no point really, if I 
wrote a living will now you might want to change your mind.”  
 Some participants held on to hope that the future might hold different options for care. 
This sense of hope sustained them in adjusting to the ramifications of their neurodegenerative 
diseases and engaging with their EOL care. “[I’ve] just got to stay fit and healthy and exercise, 
take my medication and hope… they have some luck with the stem cell testing” (Hudson, Toye, 
                                                 
3
 A general practitioner, also known as a family physician or primary care physician is a medical doctor 
who works in the community and takes a holistic rather than specialist approach to treating illnesses. 
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& Kristjanson, 2006, p.89). This quote illustrates how some participants were hopeful for future 
recovery. This contrasts with participants who had come to terms with the prospect of dying, 
some of whom had advance care directives in place stating their wishes for specific eventualities. 
Care can’t meet all of your needs 
Participants described varied and individualised care needs, including emotional, physical 
and practical support. Often the care received was inadequate and viewed as difficult to access 
and a demanding experience. For example, the quality of interaction with healthcare 
professionals was sometimes poor and consequently a barrier to care. “And now I get pats on the 
cheek or, worst of all, on the head, like a child. So I hate it. That patronizes compassion. So far 
from compassion and empathy” (Rosengren, Gustafsson, & Jarnevi, 2015, p.79). 
Often the promise of care was different to the reality and participants were left 
disappointed by the service they received. One participant spoke about how support groups, 
designed to provide psychosocial support, were unhelpful.  
I guess I don’t really need to be around people like that at this stage… what are you going 
to do? Sit around and talk about how much you shake at night… it might tend to be a 
little depressing for the type of person that I am at the moment (Hudson, Toye, & 
Kristjanson, 2006, p.90). 
Accordingly, specialist support services were highly valued, where healthcare 
professionals were well informed about their disease and able to provide continuity of care. “If I 
have any questions I visit the professor. And my GP, he doesn’t really know about the disease” 
(Booij et al., 2013, p.328). “I have all the information from the MS Society, what’s the best brand 
of car, lift, everything, grants…” (Wollin, Yates, & Kristjanson, 2006, p.23). 
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Often negative emotions were associated with the inadequacy of care. However, many 
participants seemed resigned to the fact that care could not meet all of their needs. They managed 
this shortcoming by selecting certain needs for professional care to address, while leaving others 
for family and friends to attend to. “I have already started to move out of my body. I’m moving 
up in the head instead. There I have my brain and my senses. The care and concern for my body, 
I leave to others.” (Rosengren et al., 2015, p.79). 
This is further evidenced by participants’ assumptions that it is not appropriate to discuss 
certain concerns with healthcare professionals.  To illustrate, some participants expressed a need 
for meaningfulness. This involved staying connected to other people and one’s own values. This 
was least commonly met by healthcare professionals and perceived as an inappropriate 
conversation topic. 
Those are pretty private things, like attitude towards life or further progress or whatever, 
and all those things you can talk about for hours, and I think that’s why the doctor doesn’t 
even bother getting into all that. Instead it’s just acute problems, and that was it 
(Galushko et al., 2014, p.278).  
Many participants expressed a wish to die at home. For them, home was a meaningful place of 
care where family could support them and sadness was expressed at the thought of this not being 
possible. “With a tracheostomy, I’m stranded to a nursing home.” (Lemoignan & Ells, 2010, 
p.211). This demonstrates how participants questioned the meaning of interventions and made 
decisions about them based on their own values and goals. 
Discussion 
This synthesis developed insight into how people with neurodegenerative diseases viewed end-
of-life care. Participants’ views appeared to shape their engagement with end-of-life care. No 
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claims of generalisability are made for the entire population of people with neurodegenerative 
diseases, yet the views within and across studies and disease conditions were remarkably similar. 
The themes ‘Importance of autonomy and control’ and ‘It’s the role of healthcare 
professionals to get the balance of information right’ are consistent with extant research into 
patient preferences for healthcare. A systematic review by Kiesler and Auerbach (2006) 
confirmed that patients vary in how active a role they play in their healthcare and how much 
responsibility they wish to take over decisions made. Moreover, when the interactional styles of 
healthcare professionals and their patients do not align, outcomes such as effectiveness of 
treatment and patient satisfaction are negatively affected. The researchers suggest that healthcare 
professionals should not interact with patients in a rigid, standardised way but in a manner that 
matches patients’ preferences for information and involvement in decision-making.  The finding 
of this metasynthesis that many participants were dissatisfied with the information given about 
their end-of-life care fits with research suggesting that healthcare professionals tend to be poor at 
communicating about end-of-life issues (Milberg & Strang, 2000). 
Empirical evidence on neurodegenerative diseases supports the significance of autonomy 
and the notion that patients wish to be informed and actively involved in their care (e.g. Joffe, 
2003; Tramonti, Bongioanni, Di Bernardo, Davitti, & Rossi, 2012). For example, focus groups 
revealed that for people with MND, feeling in control of care is of key importance (Cooney & 
Weaver, 2012). Similarly, lack of information has been found to be a barrier to effective care of 
people with neurodegenerative diseases (Kristjanson, Aoun, & Yates, 2006). However, it is 
noteworthy that some people want little or no role in decision-making (Benbassat, Pilpel, & 
Tidhar, 1998; Say, Murtagh, & Thomson, 2006).  
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Congruently, a minority of participants in this synthesis preferred healthcare 
professionals to make decisions about their care. It is possible to view this in a positive way, as 
individuals paradoxically exercising their autonomy and control by giving their responsibility for 
decision-making to healthcare professionals s. However, Rodin, Timko and Harris (1985) 
suggest that people who perceive less self-control tend to take less accountability for their health, 
be less likely to make use of health protective behaviours and have lower immunological 
response. 
Locus of control, a construct from Rotter’s social learning theory (1954), may offer a 
useful perspective. Levenson (1973) distinguished three sources of control: internal, powerful 
others and chance. A narrative synthesis by Eccles and Simpson (2011) suggested that wellbeing 
was associated with greater perceived control over life and that older people viewed their health 
as being controlled by powerful others such as doctors more than younger people. Age and 
perceived control may therefore account for the differences observed in this synthesis.  
This corresponds with one of the principles of self-determination theory in health 
contexts (Deci & Ryan, 2008), which proposes that increasing an individual’s autonomy and 
competence will facilitate internalisation of health protective behaviours and lead to behaviour 
change. Consequently it is argued here that, although different people may enact autonomy in 
different ways, a shared decision-making paradigm is preferable, where patients and 
professionals make decisions together on the best available evidence (Stiggelbout et al., 2012).  
The theme ‘Decision-making occurs in context’ fits with previous work demonstrating 
that families are often aware of their needs and value planning for the future (e.g. Dawson, 
Kristjanson, Toye, & Flett, 2004). Foley (2014a) argues that often research individualises 
people’s trajectories through terminal illness, divorcing their views from their social context. 
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Illness is positioned at an individual level whereas it may be more helpful to view 
neurodegenerative disease at a family level. This assertion is supported by research by Maxted, 
Simpson and Weatherhead (2014), which explored HD in family dyads. The findings suggested 
that the family members, who reported changes in identity and role, experience the impact of the 
condition. Additionally, a comprehensive review of MND family caregivers by Aoun et al. 
(2013) found that MND family caregivers experienced considerable distress and emphasised the 
need for psychosocial support for caregivers. 
Research suggests that stage of disease is important, particularly in relation to desire for 
hastened death. For example, Paulsen, Hoth, Nehl and Stierman (2005) suggest that a critical 
period for HD is just before diagnosis and also when the affected individual feels they are about 
to lose their autonomy. It is possible that this contextual factor accounts for the variance in views 
across studies in the synthesis. Disease stage is also relevant because cognitive impairment is 
prevalent in neurodegenerative diseases. Some studies show that this happens earlier in disease 
trajectory than previously thought (e.g. Patti et al., 2009). Therefore, where possible, discussions 
about care should be facilitated early. 
Social comparison was largely a negative experience for participants. The consequences 
of social comparison processes have been found to be determined largely by the degree of 
control individuals feel they have (Michinov, 2005), with upward comparisons producing a more 
positive effect when an individual perceives they have the ability to significantly alter events. 
This suggests that participants may have perceived themselves to have low self-control. 
This fits with the concept of ‘possible selves’, coined by Markus and Nurius (1986). The 
term refers to an individual’s ideas of what s/he might become. The authors suggest that possible 
selves arise from social comparisons of one’s thoughts, feelings and behaviours to those of 
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salient others. Using this conceptual framework, participants who witnessed the decline of a 
close family member may have been confronted with their ‘feared selves’. Consistent with self-
regulation theory (Cameron & Leventhal, 2003), attempts to avoid similar situations may 
therefore be a way of minimising the impact of perceived threat. Similarly, the participants who 
hoped for a cure in the future did not have vague ideas of future medical advances but held a 
strong image of their ‘desired selves’ as recovered. This theory is supported by a study by 
French, Sutton, Marteau and Kinmonth (2004) exploring the effect of providing social 
comparison information on risk perception. It was found that positive comparisons lowered 
perceptions of risk compared to unfavourable comparisons and no social comparison 
information. 
The final theme ‘Care can’t meet all your needs’ attempts to capture the complex and 
variable needs of participants as well as their implicit understanding that these needs could not 
be fully met by care. The inadequate care described by participants mirrors the experiences of 
people with neurodegenerative diseases represented in empirical literature. For example, families 
of people with dementia frequently complain of insufficient symptom control and inadequate 
advance-care planning (McCarthy, Addington-Hall, & Altmann, 1997). In support of 
participants’ appreciation of specialist services, research by van der Eijk, Faber, Al Shamma, 
Munneke and Bloem (2011) found that focus groups of patients with PD valued PD expertise in 
healthcare professionals. Similarly, best practice guidelines in relation to care for people with 
neurodegenerative diseases, such as the UK National End of Life Care Intelligence Network 
framework (2010), advocate a multidisciplinary approach.  
The shortcomings in care identified by participants were largely related to their 
psychosocial needs rather than unmet biological or medical needs. Despite the widespread 
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acceptance of the biopsychosocial model of health (Engel, 1980) and subsequent move towards 
the delivery of holistic healthcare (e.g. in European and USA healthcare), Brown, Alaszewski, 
Swift and Nordin (2011) argue that the purpose of medicine is still perceived to be to correct the 
‘problematic body’. Likewise, for HD, Nance (2007, p.176) states that “the role of the physician 
is to identify patient symptoms for which there are medical treatments, and to write prescriptions 
for the appropriate medications”, while acknowledging that most doctors take a broader role. 
Evidence suggests that this conceptualisation is at odds with the needs of patients. For 
example, studies by Ho, Gilbert, Mason, Goodman and Barker (2009) and Simpson, Lekwuwa 
and Crawford (2014) found that mental health variables were more influential than physical ones 
in determining health-related quality of life in people with PD. Furthermore, Chiò et al. (2004) 
found that physical condition was immaterial in the appreciation of quality of life for people with 
MND. Perceived quality of social support was the most highly associated domain, while 
psychological and spiritual factors were also explicatory. This supports the argument for the 
usefulness of a palliative care approach in neurodegenerative diseases, which fundamentally 
addresses the psychological, interpersonal and spiritual as well as the physical aspects of care 
(Morrison & Meier, 2004). 
The synthesis revealed that not only the effectiveness of interventions was significant but 
meaningfulness to participants. This corresponds with the existential domain of palliative care. 
Loss of meaning is particularly relevant for this population. People with neurodegenerative 
diseases may experience loss of role, everyday activities and future plans which are often 
perceived to be meaningful. Although meaning cannot be imposed (Chochinov & Breitbart, 
2009), healthcare professionals have a potential role facilitating individuals’ meaning making. 
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The importance of trust in healthcare is widely represented in medical literature. 
Interpersonal trust is considered to be essential in effective healthcare professional-patient 
relationships and good health outcomes (Brown et al., 2011). At a wider level, Mechanic (1996) 
asserts that healthcare is one of the most trusted social institutions. Studies have shown that lack 
of trust in healthcare professionals is associated with non-disclosure of problems and 
disengaging in care (Priebe, Watts, Chase, & Matanov, 2005); this mirrors the experiences of 
participants in this metasynthesis. Thom, Hall and Pawlson (2004) suggest that the need for trust 
stems from the inherent vulnerability of patients due to their illness and lack of expert 
knowledge. Further, patients want to trust that healthcare professionals are competent and will 
act in their best interests.  
Therapeutic alliance is a useful construct with which to view trust in healthcare 
relationships. Research has demonstrated that the quality of the alliance is the most robust 
predictor of successful outcomes in psychotherapy. One of the important aspects of therapeutic 
alliance is the bond: the connection between the therapist and client. MacEwan (2008) argues 
that this represents the trust between the two participants in the relationship. This could be 
translated effectively in non-psychotherapy contexts; healthcare professionals could appraise the 
therapeutic alliance in end-of-life care, paying particular attention to the bond. 
Practice Implications 
A palliative care approach would be beneficial to many people with neurodegenerative 
disease. Timing is important here as some participants reflected that they wished to ‘live in the 
moment’ and the disease trajectory of many neurodegenerative conditions is long. Therefore, 
although it is generally beneficial to involve care early, an individualised approach is needed 
here, with high quality care provided over time at the degree to which it is required. More 
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widely, this will require a shift in care provision from the more common model of crisis 
management to a framework of chronic care. This should include anticipating disease milestones 
and addressing them in a timely way to prevent crises and loss of autonomy. This may take the 
form of an advance care directive. 
Healthcare professionals should support individuals’ autonomy and provide adequate 
information to allow individuals to participate fully in the shared decision-making process. There 
is a need for information to be individualised. It is well documented that people remember a 
minority of the information given to them by healthcare professionals (Kessels, 2003). Therefore, 
repetition and visual memory aids would also be helpful, especially in the context of increasing 
problems with cognition. 
Moreover, healthcare professionals should not only provide information but also the 
context for discussions, for example, by signalling early on that they are responsible for the 
patient’s end-of-life care needs and encouraging any questions or viewpoints, including around 
death. Additionally, healthcare professionals should correct any misapprehensions the individual 
or family might have, such as the idea that advance care directives are only useful for people at 
terminal stages or that specific care can be demanded. Healthcare professionals should involve 
families where possible to ensure that the needs of the family as a whole are met but 
simultaneously ensure that the affected individual’s voice is not lost in decision-making 
processes. This is concordant with European guidelines for integrated palliative care in non-
cancer conditions (see Siouta et al., 2016 for a review) 
It is noteworthy that the legal status of assisted dying was different in the countries 
represented in the selected studies. Participants were broadly in favour of assisted dying, 
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therefore, this study supports the argument for legal provision for assisted dying and should be 
taken into account in countries where assisted dying is illegal. 
Limitations 
While every effort was made to search for articles systematically and thoroughly, this is 
not a comprehensive review. The search strategy chosen relied on database descriptors and 
subject headings and as a result these limit the scope. Additionally, the selection of studies 
published in English is a limitation; relevant studies in other languages may exist. However, 
Doyle (2003) argues that the sample for qualitative review is justifiably purposive, not 
exhaustive because the aim is interpretation, not prediction.  
An inherent issue of metasynthesis is that the findings are twice removed from the actual 
views and lived experiences of people. The findings are an interpretation of the interpretations of 
the original researchers. 
Finally, although the synthesis found consistency across papers and neurodegenerative 
diseases share many features, they are heterogeneous conditions. For example, the median life 
expectancy for MND is 2–5 years after diagnosis (Mitchell & Borasio, 2007) whereas HD is 
around 20 years (S. A. Simpson, 2007). It is possible that some views on end-of-life care, such as 
around desire for hastened death, might differ between these populations. 
 Future research 
As qualitative studies considering how stage of disease affects views on end-of-life care 
and desire for hastened death are limited, future research with people with neurodegenerative 
diseases could address this gap. Additionally, future research should seek to understand how best 
to assess the needs of people with neurodegenerative diseases. This is a key prerequisite to 
creating and implementing care interventions that meet the needs of people with 
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neurodegenerative diseases. Barriers to implementing a palliative care approach for non-cancer 
patients should also be identified and guidance put in place to remove them. 
Conclusion 
 This synthesis offers an enhanced understanding of the views of people with 
neurodegenerative diseases on EOL care by providing theoretically saturated data from the 
analysis, beyond what would be gleaned from individual studies. This synthesis suggests that the 
care needs of people with neurodegenerative diseases are routinely not being met, that autonomy 
and a sense of control are key, that views are contextual and local, and that personality traits 
(such as the meaning participants make, their beliefs and their preferences for information) shape 
engagement with care. Personality has been found to be important in many fields of medicine 
(Wallston, Wallston, & DeVellis, 1978). This is particularly important given that personality 
changes have been reported in neurodegenerative diseases such as AD and PD.  
Also, this synthesis identifies the importance of social context and recommends that care 
should be individualised and placed in the context of the life of the individual. It clearly 
advances the case for palliative care for people with neurodegenerative diseases. It is argued here 
that this should be implemented in a needs-based, integrated way across the disease trajectory as 
opposed to a traditional, symptom-led approach.  
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Booij (2013) 2 2 1 2 2 1 2 2 2 2 
Buchardi 
(2005) 
2 2 1 1 1 1 2 2 2 2 
Foley 
(2014a) 
2 2 2 2 1 2 2 1 2 2 
Foley  
(2014b) 
2 2 2 2 1 2 2 1 2 2 
Galushko 
(2014) 
2 2 2 2 1 0 0 2 2 2 
Giles (2009) 2 2 1 2 1 1 2 2 2 2 
Greenaway 
(2015) 
2 2 2 2 1 1 2 2 2 2 
Hudson 
(2006) 
2 2 2 2 1 2 2 2 2 2 
Lemoignan 
(2010) 
2 2 2 2 1 1 2 2 2 2 
Poppe (2013) 2 2 1 2 1 1 2 1 1 1 
Rosengren 
(2015) 
2 2 1 0 1 1 0 1 2 2 
Whitehead 
(2011) 
2 2 2 2 1 2 2 2 2 2 
Wollin (2006) 2 2 2 2 1 1 2 2 2 1 
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Table 3. Summary information of the studies included in the metasynthesis 
1st Author, Title, Year and Country Aims Method Analysis (Total) number, 








Booij. Euthanasia and advance 
directives in Huntington’s disease: 
Qualitative analysis of interviews 
with patients (2013, The 
Netherlands) 
To obtain in-depth information about 
patients’ thoughts on and attitudes to 
euthanasia, physician-assisted 
suicide and the use of advance 
directives in Huntington’s Disease 
Semi-structured in-depth 
interviews 
Qualitative analysis based 
on grounded theory 
(14) 8 women, 
28-70 
Background of EOL 
issues, presence of 
wishes, knowledge of 
advance directives, role of 
family and physician 
18 
Burchardi. Discussing living wills. 
A qualitative study of a German 
sample of neurologists and 
amyotrophic lateral sclerosis 
patients (2005, Germany) 
To investigate how neurologists 
provide information about living 
wills to Amyotrophic Lateral 
Sclerosis patients. To explore if 
discussions met patients’ needs and 
expectations. 
Semi-structured interviews Grounded theory 
techniques 
(15), 5 women, 
43-78, M= 59 
Healthcare professional 
biases, timing of 
interventions, importance 
of choice, importance of 
trust, desire to hasten 
death, aim to reduce 
suffering, future decline 
 
16 
Foley. Acceptance and decision 
making in amyotrophic lateral 
sclerosis from a life-course 
perspective (2014a, Ireland) 
To identify key psychosocial 
processes that underpin how and why 
people with Amyotrophic Lateral 
Sclerosis engage with services. 
In-depth interviews Grounded theory (34) 17 women, 
37-81,  
Life and death, 
acceptance, family 
context to decision 
making, views on assisted 
dying,  
18 
Foley. Understanding psycho-social 
processes underpinning engagement 
with services in motor neurone 
disease: A qualitative study (2014b, 
Ireland) 
To identify key psychosocial 
processes that underpin how and why 
people with motor neurone disease 
engage with services. 
In-depth interviews Grounded theory (34) 17 women, 
37-81,  
Control over care, 
reassurance from 
healthcare professionals, 
importance of trust, 
meaning of life, meaning 
of interventions 
18 
Galushko. Unmet needs of patients 
feeling severely affected by multiple 
sclerosis in Germany: A qualitative 
study (2014, Germany) 
To explore the subjectively unmet 
needs of patients feeling severely 






(15) 9 women, 
23-73, M= 47  
Inadequacy of care, 
family context, trust/lack 




Giles. Palliative stage Parkinson’s 
disease: patient and family 
experiences of health-care services 
(2009, Canada) 
To understand the lived healthcare 
experiences of people with 
Parkinson’s and their families and 
the needs flowing from these 
experiences. 
Semi-structured  in-depth  





(2) 2 women, 
75-77, M= 76  
Missing information, 
being on your own, 
meaning and identity 
17 
Greenaway. Accepting or declining 
non-invasive ventilation or 
gastronomy in amyotrophic lateral 
sclerosis: patients’ perspectives 
(2015, United Kingdom) 
To identify factors associated with 
decisions made by patients with  
amyotrophic lateral sclerosis to 
accept or decline non-invasive 
ventilation or gastronomy 
Semi-structured interviews Thematic analysis (21) 8 women 
women, 41-76 
Perceptions of choice, 
fear, perceived need and 
acceptance, influence and 
support of healthcare 
professionals, trust, 
18 












Hudson. Would people with 
Parkinson’s disease benefit from 
palliative care? (2006, Australia) 
To describe the experience of 
Parkinson’s disease and consider the 
relevance of palliative care for this 
population 
Semi-structured interviews Thematic analysis (8) 4 women, 
40->80 
Contextual factors, 





Lemoignan.  Amyotrophic lateral 
sclerosis and assisted ventilation: 
how patients decide (2010, Canada) 
To better understand the experience 
of decision-making about assisted 
ventilation for amyotrophic lateral 
sclerosis patients 
Semi-structured interviews Qualitative 
phenomenology 
methodology  
(9) 3 women, 
36-72 
Meaning of intervention, 
importance of context, 
importance of values 
(autonomy), effect of 




Poppe. Qualitative evaluation of 
advanced care planning in early 
dementia (ACP-ED) (2013, United 
Kingdom) 
To explore the acceptability of 
discussing advanced care planning 
with people with memory problems 
and mild dementia shortly after 
diagnosis 
In-depth interviews Constant comparison 
method 
(12) 8 women, 
68-88, M= 79 
Information needs, 
anxiety about future, 
reassurance from 
healthcare professionals,  
14 
Rosengren. Every second counts: 
Women’s experience of living with 
amyotrophic lateral sclerosis in the 
end-of-life situations (2015, 
Sweden) 
To describe patients’ experiences of 
living with ALS in the end-of-life 
situations 






care needs, context to 
decision making 
12 
Whitehead. Experiences of dying, 
death and bereavement in motor 
neurone disease: a qualitative study 
(2011, United Kingdom) 
To explore the experiences of people 
with motor neurone disease, current 
and bereaved carers in the final 
stages of the disease and 
bereavement period 
Narrative interviews Thematic analysis (24) 16 women, 
25-84 
Fears for the future, 
Information seeking, 
social and family context, 
life and death, wishes and 
decision making, 
importance of choice, 
influence of healthcare 
professionals, euthanasia 
19 
Wollin. Supportive and palliative 
care needs identified by multiple 
sclerosis patients and their families 
(2006, Australia) 
To identify the supportive needs of 
individuals with multiple sclerosis 
and their families 
In-depth semi-structured 
interviews 
Content analysis (13) 6 women, 
23-55 
Lack of support, tracking 
down services and 
information,  
17 
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Figure 1. Search process flow chart. 
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Should you have any queries, please visit our Author Services website or contact us at 
authorqueries@tandf.co.uk.  
 
This journal uses ScholarOne Manuscripts (previously Manuscript Central) to peer review 
manuscript submissions. Please read the guide for ScholarOne authors before making a 
submission. Complete guidelines for preparing and submitting your manuscript to this journal 
are provided below.  
  
Use these instructions if you are preparing a manuscript to submit to Mortality. To explore our 
journals portfolio, visit http://www.tandfonline.com/, and for more author resources, visit our 
Author Services website. 
Mortality considers all manuscripts on the strict condition that 
 the manuscript is your own original work, and does not duplicate any other previously 
published work, including your own previously published work. 
 the manuscript has been submitted only to Mortality; it is not under consideration or peer 
review or accepted for publication or in press or published elsewhere. 
 the manuscript contains nothing that is abusive, defamatory, libellous, obscene, 
fraudulent, or illegal. 
  
Please note that Mortality uses CrossCheck™ software to screen manuscripts for unoriginal 
material. By submitting your manuscript to Mortality you are agreeing to any necessary 
originality checks your manuscript may have to undergo during the peer-review and production 
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Any author who fails to adhere to the above conditions will be charged with costs which 
Mortality incurs for their manuscript at the discretion of Mortality’s Editors and Taylor & Francis, 
and their manuscript will be rejected. 
This journal is compliant with the Research Councils UK OA policy. Please see the licence 
options and embargo periods here.  
Manuscript preparation 
1. General guidelines 
↑Back to top.  
 Manuscripts are accepted in English. British English spelling and punctuation are 
preferred. Please use single quotation marks, except where ‘a quotation is “within” a 
quotation’. Long quotations of 40 words or more should be indented without quotation 
marks. 
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 A typical manuscript will not exceed 8000 words including tables, references, captions, 
footnotes and endnotes. Manuscripts that greatly exceed this will be critically reviewed 
with respect to length. Authors should include a word count with their manuscript. 
 Manuscripts should be compiled in the following order: title page; abstract; keywords; 
main text; acknowledgements; references; appendices (as appropriate); table(s) with 
caption(s) (on individual pages); figure caption(s) (as a list). 
 Abstracts of 200 words are required for all manuscripts submitted. 
 Each manuscript should have 5 to 6 keywords. 
 Search engine optimization (SEO) is a means of making your article more visible to 
anyone who might be looking for it. Please consult our guidance here. 
 Section headings should be concise. 
 All authors of a manuscript should include their full names, affiliations, postal addresses, 
telephone numbers and email addresses on the cover page of the manuscript. One author 
should be identified as the corresponding author. Please give the affiliation where the 
research was conducted. If any of the named co-authors moves affiliation during the peer 
review process, the new affiliation can be given as a footnote. Please note that no changes 
to affiliation can be made after the manuscript is accepted. Please note that the email 
address of the corresponding author will normally be displayed in the article PDF 
(depending on the journal style) and the online article. 
 All persons who have a reasonable claim to authorship must be named in the manuscript 
as co-authors; the corresponding author must be authorized by all co-authors to act as an 
agent on their behalf in all matters pertaining to publication of the manuscript, and the 
order of names should be agreed by all authors. 
 Please supply a short biographical note for each author. 
 Please supply all details required by any funding and grant-awarding bodies as an 
Acknowledgement on the title page of the manuscript, in a separate paragraph, as 
follows:  
o For single agency grants: "This work was supported by the [Funding Agency] 
under Grant [number xxxx]." 
o For multiple agency grants: "This work was supported by the [Funding Agency 
1] under Grant [number xxxx]; [Funding Agency 2] under Grant [number xxxx]; 
and [Funding Agency 3] under Grant [number xxxx]." 
 Authors must also incorporate a Disclosure Statement which will acknowledge any 
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